Newly Diagnosed with Crohn's Disease? Join EXPLORER Research Study Participants may be eligible if they Explorer is a clinical research study designed to learn if a combination of 3 FDA-approved drugs-vedolizumab, adalimumab, and oral methotrexate work when taken together in Are between 18 and 65 years of age Currently have moderate to severe CD Are at high risk for complications which will be assessed at time of screening patients newly diagnosed with Crohn's disease. The use of these drugs in this study is investigational. The study doctor will discuss additional criteria for the research study should you choose to participate. Local gastroenterologist Dr. Glenn Freed has partnered with Care Access Research to bring this clinical research study option for patients with Crohns. Call to learn more or visit our website. (570) 478-5120 ExplorerStudy.com CareAccess RESEARCH Newly Diagnosed with Crohn's Disease? Join EXPLORER Research Study Participants may be eligible if they Explorer is a clinical research study designed to learn if a combination of 3 FDA-approved drugs-vedolizumab, adalimumab, and oral methotrexate work when taken together in Are between 18 and 65 years of age Currently have moderate to severe CD Are at high risk for complications which will be assessed at time of screening patients newly diagnosed with Crohn's disease. The use of these drugs in this study is investigational. The study doctor will discuss additional criteria for the research study should you choose to participate. Local gastroenterologist Dr. Glenn Freed has partnered with Care Access Research to bring this clinical research study option for patients with Crohns. Call to learn more or visit our website. (570) 478-5120 ExplorerStudy.com CareAccess RESEARCH